A little known law that made drugs more affordable

Years ago, when a brand-name medication’s patent expired, consumers had to wait a long time for a more affordable generic version to come to market. But in 1984, a little-known law put an end to that waiting period and paved the way for the large quantity of generic drugs available today.
The Drug Price Competition and Patent Term Restoration Act of 1984 - also known as the "Hatch-Waxman Act" after the two legislators who sponsored the bill - makes it easier for generic drugs to enter the industry, including allowing generic drugmakers to start research and development on generics prior to the patent expiration of the brand-name drug without risk of patent infringement. In return, brand-name drugmakers were given a patent extension - five extra years of market exclusivity on their drug.
But Hatch-Waxman isn’t a perfect law. In this video, we explain how the Hatch-Waxman Act works to extend brand-name drug patent protection and also facilitate generic drug market entry, but also how it is limited in its power. We also cover other patent extensions that are used to delay generic drug entry and the ways this can affect consumers.
More from STAT:
Become a subscriber: www.statnews.c...
Watch Full Episodes: / @statnews
Newsletters: www.statnews.c...
STAT events: www.statnews.c...
Facebook: / statnews
Twitter: / statnews
Instagram: / statnews
Flipboard: rb.gy/3xnsxr
STAT Reports: rb.gy/rexfwj
STAT eBooks: rb.gy/eme3h5
ABOUT STAT:
Founded in 2015, STAT is a global digital media brand that focuses on delivering fast, deep, and tough-minded journalism about the life sciences industries to over six million monthly site visitors and an additional 20 million readers on the Apple News app. STAT takes you inside academic labs, biotech boardrooms, and political backrooms, casting a critical eye on scientific discoveries, scrutinizing corporate strategies, and chronicling the roiling battles for talent, money, and market share. With an award-winning newsroom, STAT provides indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life sciences industry - and a revolution in human health.

[@Esorh]

Great and digestible video! Thank you!!